Talis Biomedical Corporation
TLIS
$1.60
-$0.08-4.76%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.85M | -13.04M | -13.46M | -15.68M | -15.03M |
| Total Depreciation and Amortization | 84.00K | 262.00K | 211.00K | 217.00K | 168.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.07M | 5.98M | 1.42M | 4.28M | 3.75M |
| Change in Net Operating Assets | -4.64M | 371.00K | 469.00K | 42.00K | -3.16M |
| Cash from Operations | -11.33M | -6.43M | -11.36M | -11.14M | -14.27M |
| Capital Expenditure | -- | -- | 93.00K | -70.00K | -485.00K |
| Sale of Property, Plant, and Equipment | 84.00K | 30.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 84.00K | 30.00K | 93.00K | -70.00K | -485.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 2.00K | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 2.00K | 0.00 | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.25M | -6.40M | -11.26M | -11.21M | -14.76M |
